.BETA.-D-GLUCOPYRANOSIDURONIC ACID, 3-(4-(4-(2-(AMINOCARBONYL)-2,3-DIHYDRO-5-BENZOFURANYL)-1-PIPERAZINYL)BUTYL)-5-CYANO-2,3-DIHYDRO-1H-INDOL-6-YL
UNII GQ8438GYV2

Substance Identification & Data

This profile provides standardized clinical and technical data for .beta.-d-glucopyranosiduronic Acid, 3-(4-(4-(2-(aminocarbonyl)-2,3-dihydro-5-benzofuranyl)-1-piperazinyl)butyl)-5-cyano-2,3-dihydro-1h-indol-6-yl, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GQ8438GYV2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 364064-15-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

GQ8438GYV2

CAS Registry Number

364064-15-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

.BETA.-D-GLUCOPYRANOSIDURONIC ACID, 3-(4-(4-(2-(AMINOCARBONYL)-2,3-DIHYDRO-5-BENZOFURANYL)-1-PIPERAZINYL)BUTYL)-5-CYANO-2,3-DIHYDRO-1H-INDOL-6-YL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C32H35N5O9

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

DXUXGQNLHNJQPD-IOTTWRDDSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

156596404

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c2[nH]cc(c2cc(c1O[C@@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C(=O)O)O3)C#N)CCCCN4CCN(CC4)c5cc6c(cc5)oc(c6)C(=O)N

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for .beta.-d-glucopyranosiduronic Acid, 3-(4-(4-(2-(aminocarbonyl)-2,3-dihydro-5-benzofuranyl)-1-piperazinyl)butyl)-5-cyano-2,3-dihydro-1h-indol-6-yl. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.